Irinotecan is a compound used as an active pharmaceutical ingredient in the manufacturing of anti-cancer medications. It is primarily applied in research and production settings for formulations targeting colon cancer and small cell lung cancer.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Irinotecan?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Irinotecan hydrochloride
pharmaceutical raw material
Irinotecan hydrochloride trihydrate
pharmaceutical raw material
Lappaconitine hydrobromide
pharmaceutical raw material
Ractopamine
pharmaceutical raw material
Raclopride c-11
pharmaceutical raw material
Ciprofloxacin lactate
pharmaceutical raw material
The international HS code for Irinotecan (CAS 97682-44-5) is 2939.79.
2939.79
2939 79 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate
UWKQSNNFCGGAFS-XIFFEERXSA-N
CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
Sourcing Irinotecan?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.